Valiant Laboratories Limited (NSE:VALIANTLAB)
83.70
-0.02 (-0.02%)
Nov 4, 2025, 3:29 PM IST
Valiant Laboratories Market Cap
Valiant Laboratories has a market cap or net worth of 4.54 billion as of November 5, 2025. Its market cap has decreased by -10.78% in one year.
Market Cap
4.54B
Enterprise Value
4.99B
Revenue
1.61B
Ranking
n/a
PE Ratio
3,515.58
Stock Price
83.70
Market Cap Chart
Since October 6, 2023, Valiant Laboratories's market cap has decreased from 7.40B to 4.54B, a decrease of -38.69%. That is a compound annual growth rate of -20.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 4.54B | -6.08% |
| Dec 31, 2024 | 4.83B | -35.84% |
| Dec 29, 2023 | 7.53B | 1.73% |
| Oct 6, 2023 | 7.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.09T |
| Divi's Laboratories | 1.81T |
| Cipla | 1.22T |
| Apollo Hospitals Enterprise | 1.13T |
| Mankind Pharma | 990.41B |
| Zydus Lifesciences | 987.17B |
| Fortis Healthcare | 778.14B |
| Alkem Laboratories | 672.97B |